Drug class · Endocrine & metabolism
DPP-4 inhibitors Drug Codes & NDCs
Oral drugs that inhibit the dipeptidyl peptidase-4 enzyme, alone or in fixed combinations.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Januviasitagliptin | Sitagliptin phosphate 50 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0112 |
| Januviasitagliptin | Sitagliptin phosphate 25 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0221 |
| Januviasitagliptin | Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0277 |
| Januviasitagliptin | Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-1036 |
| Januviasitagliptin | Sitagliptin phosphate 50 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-3472 |
| Januviasitagliptin | Sitagliptin phosphate 25 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-3527 |
| Januviasitagliptin | Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-4084 |
| Januviasitagliptin | Sitagliptin phosphate 50 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-4086 |
| Januviasitagliptin | Sitagliptin phosphate 25 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-4087 |
| Januviasitagliptin | Sitagliptin phosphate 50 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-5040 |
| Januviasitagliptin | Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-5042 |
| Jentaduetolinagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0146 |
| Jentaduetolinagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 850 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0147 |
| Jentaduetolinagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0148 |
| Jentadueto XRlinagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0270 |
| Jentadueto XRlinagliptin and metformin hydrochloride | Linagliptin 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0275 |
| Kazanoalogliptin and metformin hydrochloride | Alogliptin benzoate 12.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-335 |
| Kazanoalogliptin and metformin hydrochloride | Alogliptin benzoate 12.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-337 |
| Linagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-407 |
| Linagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 850 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-408 |
| Linagliptin and metformin hydrochloride | Linagliptin 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Novadoz Pharmaceuticals LLC | 72205-409 |
| Nesinaalogliptin | Alogliptin benzoate 12.5 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-125 |
| Nesinaalogliptin | Alogliptin benzoate 25 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-250 |
| Nesinaalogliptin | Alogliptin benzoate 6.25 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-625 |
| Osenialogliptin and pioglitazone | Alogliptin benzoate 12.5 mg/1; Pioglitazone hydrochloride 30 mg/1 | Tablet, Film coatedOral | Takeda Pharmaceuticals America, Inc. | 64764-123 |